Skip to main content

Table 2 Intra-mouthrinse comparisons of viability of salivary microbiota (%), measured under CLSM, after treatment with placebo (sterile water), CPC, O-cymen-5-ol, and CPC + O-cymen-5-ol.

From: Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial

Time (in min)

Mouthrinse

Mean ± SD

95% Conf. Interval

p-value

15 min

Placebo

86.3 ± 10.7

79.14–93.48

0.09

CPC

54.8 ± 23.0

41.50–68.06

< 0.001

O-Cymen-5-ol

76.3 ± 17.1

66.36–86.14

< 0.001

CPC + O-Cymen-5-ol

47.4 ± 11.9

40.49–54.30

< 0.001

30 min

Placebo

95.3 ± 16.0

84.53–106.01

0.86

CPC

67.4 ± 22.7

54.25–80.44

< 0.001

O-Cymen-5-ol

84.4 ± 12.9

76.97–91.89

< 0.05

CPC + O-Cymen-5-ol

56.2 ± 12.7

48.88–63.49

< 0.001

1 h

Placebo

92.1 ± 5.9

88.15–96.09

0.48

CPC

68.0 ± 17.0

58.20–77.83

< 0.001

O-Cymen-5-ol

82.0 ± 12.4

74.80–89.10

< 0.05

CPC + O-Cymen-5-ol

58.7 ± 8.9

53.54–63.87

< 0.001

2 h

Placebo

93.0 ± 11.1

85.54–100.52

0.58

CPC

68.9 ± 19.5

57.65–80.14

< 0.001

O-Cymen-5-ol

88.2 ± 8.0

83.57–92.80

0.14

CPC + O-Cymen-5-ol

60.5 ± 18.0

50.11–70.86

< 0.001

3 h

Placebo

95.3 ± 8.0

89.94–100.69

0.87

CPC

79.3 ± 18.5

68.63–90.06

< 0.001

O-Cymen-5-ol

92.0 ± 9.9

86.34–97.73

0.44

CPC + O-Cymen-5-ol

67.2 ± 11.8

60.44–74.05

< 0.001

4 h

Placebo

96.2 ± 8.3

90.63–101.84

0.88

CPC

93.1 ± 22.8

79.95–106.29

0.57

O-Cymen-5-ol

94.1 ± 9.1

88.84–99.40

0.70

CPC + O-Cymen-5-ol

81.4 ± 13.8

73.45–89.43

< 0.05

  1. *ANOVA with repeated measures was used to calculate the p-value
  2. SD Standard deviation